跳至主要内容
临床试验/NL-OMON29216
NL-OMON29216尚未招募不适用

Pharmacological Magnetic Resonance Spectroscopy

Amsterdam University Medical Center, location AMC0 个研究点目标入组 30 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • ? Healthy volunteers between 18 and 55 years old;
  • ? BMI between 18.5 and 25;
  • ? Male or female;
  • ? If female: using oral contraceptives and not in hormone-free week during scanning

排除标准

  • ? (History of) psychiatric treatment, for which prescription medication is used;
  • ? First-degree relative with (history of) schizophrenia or major depression;
  • ? (History) of neurological disorders (including stroke, convulsion, epilepsy) as well as concussion
  • with loss of consciousness
  • ? Contraindications for S-ketamine (e.g. allergy for S-ketamine, or one of the inactive ingredients
  • of this product, high BP (RRsystolic > 180 mmHg or diastolic >100 mmHg), use of xantiderivatives
  • or methylergometrine); use of substances that interact with S-ketamine (e.g. grapefruit juice, antifungal medication)
  • ? Contraindications for 7T MRI (e.g. claustrophobia, osteosynthetic material, pacemaker, artificial
  • cardiac valves);
  • ? (History of) drug (opiate, LSD, (meth)amphetamine, cocaine, solvents, cannabis, or barbiturate)
  • or alcohol dependence;
  • ? Used psychotropic medication, or recreational drugs over a period of 1 week prior to each test
  • ? Used alcohol within the last 24 hours prior to each test session.

研究者

发起方
Amsterdam University Medical Center, location AMC

相似试验